Easter break office closure 

We will be closed from 5pm Thursday 17 April 2025 until 10am Tuesday 22 April 2025. You can still submit your complaint via our online form but we will not respond until we reopen.

New Customer Service Standards

We have updated our Customer Service Standards and are looking for feedback from customers. Please fill out our survey here by 12 May 2025: https://forms.office.com/e/ZDpjibqe8r 

Decision Report 201800349

  • Case ref:
    201800349
  • Date:
    February 2019
  • Body:
    Grampian NHS Board
  • Sector:
    Health
  • Outcome:
    Not upheld, no recommendations
  • Subject:
    clinical treatment / diagnosis

Summary

Mr C was attending the endocrinology (the branch of medicine concerned with endocrine glands and hormones) department at Aberdeen Royal Infirmary for tests associated with his body's ability to make a natural steroid hormone. Several month's later he suffered a stroke and he believed that this was a result of him taking testosterone replacement therapy. Mr C complained that during a clinic attendance he was not warned about the risks and benefits of this therapy.

We took independent endocrinology advice. We found that Mr C had been prescribed testosterone replacement therapy by his GP and that it was the responsibility of the prescribing doctor to discuss the risks and benefits with him. When hospital clinicians became aware of the testosterone therapy, they contacted the GP practice to obtain more information and suggested a way forward. We considered this to be reasonable and did not uphold Mr C's complaint.

Updated: February 20, 2019